Distek, Inc. launches new product that extends the capabilities of the symphony 7100

NewsGuard 100/100 Score

Distek, Inc., a leading manufacturer of pharmaceutical laboratory testing instruments, accessories and validation services for over 40 years, announced today the release of their small volume conversion kit for the symphony 7100 bathless dissolution tester, combining the advantages of bathless instruments with small sample volumes.

Distek’s small volume conversion kit extends the symphony 7100’s unique ability to run up to three different temperatures and agitation speeds to much lower volumes ranging from 30 – 100 mL. This allows formulators to perform rapid dissolution or solubility evaluations using minimum amounts of API.  This new kit is compatible with conventional manual or semi-automated sampling techniques as well as in-situ UV Fiber Optics.

About Distek, Inc.

Distek, Inc. is a leading manufacturer of laboratory testing instruments for the pharmaceutical and biotechnology industry for over 40 years, as well as an experienced provider of validation and qualification services.

Distek engineers highly innovative, technically modern and user-friendly instruments that provide many innovative features to customers, worldwide. Distek’s core market includes brand name and generic pharmaceutical drug manufacturers, CRO’s, CMO’s, Nutraceuticals, government agencies, and universities. Distek holds several instrumentation and accessory patents and has been ISO certified since 2002.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals avocado may lower diabetes risk in women, not men